---
title: Correlation of tumor PD-L1 expression in different tissue types and outcome
  of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective
  multicenter cohort study ADOREG/TRIM
date: '2023-09-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37660535/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230904181134&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'BACKGROUND: PD-1-based immune checkpoint inhibition (ICI) is the major
  backbone of current melanoma therapy. Tumor PD-L1 expression represents one of few
  biomarkers predicting ICI therapy outcome. The objective of the present study was
  to systematically investigate whether the type of tumor tissue examined for PD-L1
  expression has an impact on the correlation with ICI therapy ...'
disable_comments: true
---
BACKGROUND: PD-1-based immune checkpoint inhibition (ICI) is the major backbone of current melanoma therapy. Tumor PD-L1 expression represents one of few biomarkers predicting ICI therapy outcome. The objective of the present study was to systematically investigate whether the type of tumor tissue examined for PD-L1 expression has an impact on the correlation with ICI therapy ...